TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Natumin Pharma AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 62,178 | 60,629 | 62,053 |
Financial expenses | 485 | 374 | 247 |
Earnings before taxes | -3,781 | -7,839 | -10,485 |
EBITDA | -2,459 | -5,992 | -8,476 |
Total assets | 51,934 | 50,119 | 46,879 |
Current assets | 35,615 | 32,678 | 26,850 |
Current liabilities | 21,972 | 20,171 | 7,902 |
Equity capital | 18,507 | 22,979 | 28,148 |
- share capital | 1,892 | 1,950 | 2,095 |
Employees (average) | 23 | 24 | 25 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 35.6% | 45.8% | 60.0% |
Turnover per employee | 2,703 | 2,526 | 2,482 |
Profit as a percentage of turnover | -6.1% | -12.9% | -16.9% |
Return on assets (ROA) | -6.3% | -14.9% | -21.8% |
Current ratio | 162.1% | 162.0% | 339.8% |
Return on equity (ROE) | -20.4% | -34.1% | -37.2% |
Change turnover | 3,371 | 2,863 | 5,059 |
Change turnover % | 6% | 5% | 9% |
Chg. No. of employees | -1 | -1 | 2 |
Chg. No. of employees % | -4% | -4% | 9% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.